TokenPost·

BrainStorm Cell Therapeutics Posts $0.68 Q3 Loss, Misses Estimate by $0.50

Your call?

Cash, cash equivalents and restricted cash totaled about $350,000 at Sept. 30, 2026, up from about $240,000 a year earlier.

Share

More news